Strain Profile
Save

Ligilactobacillus salivarius

◔ Human-origin
Sequenced
Public genome assembly available

Ligilactobacillus salivarius (species-level entry, no specific strain designation) is an oral and intestinal lactic acid bacterium studied across several strains for immune modulation and respiratory health. A randomized controlled trial examined L. salivarius LS01 in children with asthma, and animal studies have examined long-term protection outcomes against Streptococcus pneumoniae in certain strains. An observational report examined immune and nutritional markers in elderly nursing home residents given another strain during the COVID-19 pandemic. Because the linked evidence spans multiple distinct strains, strain-specific conclusions cannot be drawn; the species has been studied in immune and respiratory contexts, but human evidence remains preliminary and strain-dependent. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.

Where it's been studied

Share of this strain's 333 body-system-tagged papers that concern each system. Research coverage, not measured effect.

+5 more systems

Symptoms in the research

Share of this strain's 93 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.

+8 more symptoms

Research

470 papers reference this strain in the probiotic database.

Match confidence
2026 IN_VITRO
Enhanced eradicative effects of postbiotics derived from Ligilactobacillus salivarius LSA-6 combined with cold plasma against Listeria monocytogenes biofilms for fresh produce preservation
· Food Bioscience
2026 IN_VITRO
Animal-sourced probiotic bacteria induce interferon gamma in humans and mice
· In Silico Research in Biomedicine
2026 WGS
Probiotic properties of Ligilactobacillus salivarius K611 isolated from chicken feces and its antibacterial activity against Salmonella Typhimurium
· Journal of Agriculture and Food Research
2026 OTHER
MassIVE MSV000100444 - Untargeted Metabolomics of Human Fecal Samples Associated with Anti-PD-1 Response and Ligilactobacillus salivarius Culture Supernatants
·
2026 ANIMAL
Targeting microbiota-generated acetaldehyde to prevent progression of metabolic dysfunction-associated steatotic liver disease
· Cell Metabolism
2026 ANIMAL
Bacterial vesicles from intratumoral L. salivarius enhance PD-1 blockade via FPR1-mediated macrophage polarization in gastric cancer
· Cell Reports Medicine
2026 IN_VITRO
Impact of selenium-enriched Ligilactobacillus salivarius DACN818 on Zhacai: Insights from metabolomics and microbiomics
· Food Chemistry X
2026 OTHER
Use of Ligilactobacillus salivarius SP36 as an Adjunct Culture by an Artisan Dairy and Isolation of New Autochthonous Strains with Technological Potential for Cheesemaking
· Foods
2026 REVIEW
The Role of Probiotics Limosilactobacillus reuteri, Ligilactobacillus salivarius, and Lactobacillus johnsonii in Inhibziting Pathogens, Maintaining Gut Health, and Improving Disease Outcomes
· International Journal of Molecular Sciences
2026 ANIMAL
From Macromolecule to Microbe: Identification of Ligilactobacillus salivarius D3-8 as a Key Degrader of Ejiao and a Novel Therapeutic Probiotic for Ulcerative Colitis
· Nutrients
2026 ANIMAL
Feline-Derived Ligilactobacillus agilis ZY25 and Ligilactobacillus salivarius ZY35 Alleviate Enteropathogenic Escherichia coli-Induced Intestinal Injury and Microbial Dysbiosis in Mice
· Microorganisms
2026 ANIMAL
A novel bile salt hydrolase-producing Ligilactobacillus salivarius prevents diet-induced obesity via regulation of bile acid metabolism and glucagon-like peptide 1 restoration
· Gut Microbes
2026 RCT
Probiotic-Containing Nanofiber-Based Dental Floss Suppresses Subgingival Red Complex Periopathogens: A Randomized Double-Blind Crossover Trial
· Probiotics and Antimicrobial Proteins
2026 ANIMAL
Effects of Ligilactobacillus salivarius on the control of pullorum disease and cecal microbiota in red-feathered native chickens
· Poultry Science
2026 ANIMAL
Ligilactobacillus salivarius Li01 enhances gut microbiota-derived indole-3-propionic acid to alleviate 5-fluorouracil-induced diarrhea in mice
· Food & Function
2026 ANIMAL
Intratumoral delivery of probiotic Ligilactobacillus salivarius H22A013 modulates the melanoma microenvironment and enhances trametinib efficacy
· BMC Microbiology
2026 ANIMAL
Behavioral, antioxidant, and kynurenine pathway modulation of a specific strain of Ligilactobacillus salivarius in a preclinical model of depression
· European Journal of Nutrition
2026 IN_VITRO
Ekstrakcija zelenog čaja i fermentacija ekstrakata pomoću Ligilactobacillus salivarius i Lactiplantibacillus plantarum
· TechnoRep (University of Belgrade – Faculty of Technology and Metallurgy)
2026 ANIMAL
Ligilactobacillus salivarius 8-2 attenuates intestinal mucosal injury in chicks via the mitochondrial fision-glycometabolism reprogramming axis
· Poultry Science
2026 IN_VITRO
Biosynthesis of Selenium Nanoparticles by Ligilactobacillus salivarius DACN818: Characterization and Mechanism
· Journal of Agricultural and Food Chemistry
Browse all 470 papers →

Discussion

Be the first to comment.

Sign in to join the discussion.

No comments yet.

Citations

Selected papers that name this strain.

  1. [1]
    Probiotic supplementation improves quality of life and modulates oestradiol in women with endometriosis: a randomised double-blind pilot trial
    · Figshare · 2026
    Source →
  2. [2]
    Probiotic-Containing Nanofiber-Based Dental Floss Suppresses Subgingival Red Complex Periopathogens: A Randomized Double-Blind Crossover Trial
    · Probiotics and Antimicrobial Proteins · 2026
    PMID 41484513 →
  3. [3]
    Correction: Assessing the Efficacy of Ligilactobacillus salivarius CLS0420 and Lacticaseibacillus paracasei CLPC0603 on Vaginal Well-Being in Healthy Women: A Pilot, Randomized, Double-Blind, Placebo-Controlled Trial
    · Probiotics and Antimicrobial Proteins · 2025
    PMID 40739452 →
  4. [4]
    Ligilactobacillus salivarius CECT5713 Increases Term Pregnancies in Women with Infertility of Unknown Origin: A Randomized, Triple-Blind, Placebo-Controlled Trial
    · Nutrients · 2025
    PMID 40507130 →
  5. [5]
    Understanding Ligilactobacillus salivarius from Probiotic Properties to Omics Technology: A Review
    · Foods · 2024
    PMID 38540885 →
  6. [6]
    Ligilactobacillus salivarius V4II-90 eradicates Group B Streptococcus colonisation during pregnancy: a randomised, double-blind, placebo-controlled trial
    · Beneficial Microbes · 2024
    PMID 38955352 →
  7. [7]
    Effect of tablets containing a paraprobiotic strain and the cranberry extract on caries incidence in preschool children: A randomized controlled trial
    · Dental and Medical Problems · 2024
    PMID 39023333 →
  8. [8]
    Ligilactobacillus salivarius CCFM 1266 modulates gut microbiota and GPR109a-mediated immune suppression to attenuate immune checkpoint blockade-induced colitis
    · Food & Function · 2023
    PMID 37953676 →
  9. [9]
    A randomized pilot trial assessing the reduction of gout episodes in hyperuricemic patients by oral administration of Ligilactobacillus salivarius CECT 30632, a strain with the ability to degrade purines
    · Frontiers in Microbiology · 2023
    PMID 36865781 →
  10. [10]
    Assessment of the safety and probiotic characteristics of Lactobacillus salivarius CGMCC20700 based on whole-genome sequencing and phenotypic analysis
    · Frontiers in Microbiology · 2023
    PMID 37007532 →